This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kathy Birk, MD; Corey Ford, MD; Suzanne Smeltzer, RN, EdD; Daniel Ryan, MD; Richard Miller, PhD; Richard A. Rudick, MD

Arch Neurol. 1990;47(7):738-742.

Abstract
• Eight women with multiple sclerosis were followed up through pregnancy. Clinical conditions, T-cell subsets, and levels of immunoactive pregnancy-associated proteins were measured twice during the pregnancy and twice during the first postpartum year. None of the women's conditions worsened during pregnancy, although one woman reported a slight increase of symptoms. Six of the eight women experienced relapses within the first 7 weeks after delivery. The number and percent of CD8 suppressor T cells were lower, and the CD4 helper-CD8 suppressor T-cell ratio was higher in the pregnant patients with multiple sclerosis compared with pregnant control women throughout pregnancy and the first 6 months post partum. There was no evident relationship between these parameters and clinical disease activity. Levels of -fetoprotein, ₂-pregnancy-associated glycoprotein, and pregnancy-associated plasma protein A, all immuno-suppressive proteins associated with pregnancy, were not significantly different in pregnant patients with multiple sclerosis and pregnant controls without multiple sclerosis. The study suggested that the risk of clinical relapse after delivery may be higher than has been reported previously. Furthermore, although there were differences in suppressor T cells, they were not predictably linked to changes in clinical disease activity.

Author Affiliations
From the Department of Obstetrics and Gynecology, The Genesee Hospital, Rochester, NY (Dr Birk); the Department of Neurology, University of New Mexico Medical Center, Albuquerque (Dr Ford); the College of Nursing, Rutgers/State University of New Jersey, New Brunswick (Dr Smeltzer); the Departments of Pathology and Laboratory Medicine (Dr Ryan) and Obstetrics and Gynecology (Dr Miller), University of Rochester (NY) School of Medicine; and the Mellen Center for Multiple Sclerosis Treatment and Research, The Cleveland (Ohio) Clinic Foundation (Dr Rudick).

Footnotes
Accepted for publication October 27, 1989.

Reprint requests to Mellen Center, The Cleveland Clinic Foundation, Cleveland, Ohio 44106 (Dr Rudick).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pregnancy Suppresses Experimental Autoimmune Encephalomyelitis through Immunoregulatory Cytokine Production
McClain et al.
J. Immunol. 2007;179:8146-8152.
ABSTRACT | FULL TEXT  

A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis
Haas and Hommes
Mult Scler 2007;13:900-908.
ABSTRACT  

Estrogen Enhances Susceptibility to Experimental Autoimmune Myasthenia Gravis by Promoting Type 1-Polarized Immune Responses
Delpy et al.
J. Immunol. 2005;175:5050-5057.
ABSTRACT | FULL TEXT  

Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands
Elloso et al.
J Endocrinol 2005;185:243-252.
ABSTRACT | FULL TEXT  

Middle-Age Male Mice Have Increased Severity of Experimental Autoimmune Encephalomyelitis and Are Unresponsive to Testosterone Therapy
Matejuk et al.
J. Immunol. 2005;174:2387-2395.
ABSTRACT | FULL TEXT  

T Lymphocytes Do Not Directly Mediate the Protective Effect of Estrogen on Experimental Autoimmune Encephalomyelitis
Polanczyk et al.
Am. J. Pathol. 2004;165:2069-2077.
ABSTRACT | FULL TEXT  

Estrogen Receptor {alpha} Signaling in Inflammatory Leukocytes Is Dispensable for 17{beta}-Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis
Garidou et al.
J. Immunol. 2004;173:2435-2442.
ABSTRACT | FULL TEXT  

Adult Gonadal Hormones Selectively Regulate Sexually Dimorphic Quantitative Traits Observed in Experimental Allergic Encephalomyelitis
Fillmore et al.
Am. J. Pathol. 2004;164:167-175.
ABSTRACT | FULL TEXT  

Estradiol Treatment Redirects the Isotype of the Autoantibody Response and Prevents the Development of Autoimmune Arthritis
Latham et al.
J. Immunol. 2003;171:5820-5827.
ABSTRACT | FULL TEXT  

Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol
Soldan et al.
J. Immunol. 2003;171:6267-6274.
ABSTRACT | FULL TEXT  

The Protective Effect of 17{beta}-Estradiol on Experimental Autoimmune Encephalomyelitis Is Mediated through Estrogen Receptor-{alpha}
Polanczyk et al.
Am. J. Pathol. 2003;163:1599-1605.
ABSTRACT | FULL TEXT  

Estrogen receptor-{alpha} mediates the brain antiinflammatory activity of estradiol
Vegeto et al.
Proc. Natl. Acad. Sci. USA 2003;100:9614-9619.
ABSTRACT | FULL TEXT  

Oral Feeding with Ethinyl Estradiol Suppresses and Treats Experimental Autoimmune Encephalomyelitis in SJL Mice and Inhibits the Recruitment of Inflammatory Cells into the Central Nervous System
Subramanian et al.
J. Immunol. 2003;170:1548-1555.
ABSTRACT | FULL TEXT  

Multiple sclerosis and pregnancy
Lorenzi and Ford
Postgrad. Med. J. 2002;78:460-464.
ABSTRACT | FULL TEXT  

Estrogen Treatment Down-Regulates TNF-{{alpha}} Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice
Ito et al.
J. Immunol. 2001;167:542-552.
ABSTRACT | FULL TEXT  

Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains
Bebo et al.
J. Immunol. 2001;166:2080-2089.
ABSTRACT | FULL TEXT  

Oral contraceptives and the incidence of multiple sclerosis
Hernan et al.
Neurology 2000;55:848-854.
ABSTRACT | FULL TEXT  

Androgens Alter the Cytokine Profile and Reduce Encephalitogenicity of Myelin-Reactive T Cells
Bebo et al.
J. Immunol. 1999;162:35-40.
ABSTRACT | FULL TEXT  

Rate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux et al.
NEJM 1998;339:285-291.
ABSTRACT | FULL TEXT  

Intravenous immunoglobulin treatment in Multiple Sclerosis and experimental autoimmune encephalomyelitis - the Israeli Experience
Achiron et al.
Mult Scler 1997;3:142-144.
 

Pregnancy and Multiple Sclerosis
Rudick
Arch Neurol 1995;52:849-850.
ABSTRACT  

Pregnancy and Multiple Sclerosis-Reply
Sadovnick
Arch Neurol 1995;52:850-850.
ABSTRACT  

The Concerns of Pregnant Women with Multiple Sclerosis
Smeltzer
Qual Health Res 1994;4:480-502.
ABSTRACT  

Pregnancy and Multiple Sclerosis: A Prospective Study
Sadovnick et al.
Arch Neurol 1994;51:1120-1124.
ABSTRACT  

Hypothesis: Calcitriol Mediates Pregnancy's Protective Effect on Multiple Sclerosis
Schwartz
Arch Neurol 1993;50:455-455.
ABSTRACT